Aurobindo Pharma Limited announced that Mr. K. Ragunathan will be retiring as an Independent Director of the Company on close of business hours of March 31, 2024, upon completion of his second term as an Independent Director of the Company. Consequently, he shall also cease to be the Chairman of Board of Directors of the Company and Member of various Committees of Board of Directors of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,198 INR | -1.64% |
|
-3.60% | +10.51% |
24/06 | INDIA STOCKS-Financials weigh on Indian shares; small-, mid-caps fall | RE |
05/06 | Hindalco-owned Novelis delays US IPO; shares slide | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.51% | 855.35Cr | |
+55.19% | 81TCr | |
+45.11% | 65TCr | |
-6.09% | 35TCr | |
+21.92% | 34TCr | |
+18.83% | 25TCr | |
+3.19% | 23TCr | |
+13.75% | 22TCr | |
+10.86% | 17TCr | |
-2.78% | 16TCr |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Aurobindo Pharma Limited Announces Retirement of K. Ragunathan as Chairman of Board of Directors, Effective March 31, 2024